The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Anti‐platelet therapy: phosphodiesterase inhibitors
Open accessAbstract
Inhibition of platelet aggregation can be achieved either by the blockade of membrane receptors or by interaction with intracellular signalling pathways. Cyclic adenosine 3′,5′‐monophosphate (cAMP) and cyclic guanosine 3′,5′‐monophosphate (cGMP) are two critical intracellular second messengers provided with strong inhibitory activity on fundamental platelet functions. Phosphodiesterases (PDEs), by catalysing the hydrolysis of cAMP and cGMP, limit the intracellular levels of cyclic nucleotides, thus regulating platelet function. The inhibition of PDEs may therefore exert a strong platelet inhibitory effect. Platelets possess three PDE isoforms (PDE2, PDE3 and PDE5), with different selectivity for cAMP and cGMP. Several nonselective or isoenzyme‐selective PDE inhibitors have been developed, and some of them have entered clinical use as antiplatelet agents. This review focuses on the effect of PDE2, PDE3 and PDE5 inhibitors on platelet function and on the evidence for an antithrombotic action of some of them, and in particular of dipyridamole and cilostazol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adenosine 3‘,5‘-Phosphate in Biological Materials
Butcher, R. W., & Sutherland, E. W. (1962) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60316-3 · Cited by 2,077
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use
Bender, A. T., & Beavo, J. A. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.5 · Cited by 1,781
Diener, H. C., Cunha, L., Forbes, C., Sivenius, J., Smets, P., & Lowenthal, A. (1996) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00308-5 · Cited by 1,577
Forbes, C., & Collaborators, E. (1997) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1997.tb11433.x · Cited by 1,411
FRACTIONATION AND CHARACTERIZATION OF A CYCLIC ADENINE RIBONUCLEOTIDE FORMED BY TISSUE PARTICLES
Sutherland, E. W., & Rall, T. W. (1958) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77423-7 · Cited by 1,076
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
Sacco, R. L., Diener, H.-C., Yusuf, S., Cotton, D., Ôunpuu, S., Lawton, W. A., Palesch, Y., Martin, R. H., Albers, G. W., Bath, P., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805002 · Cited by 961
Schwartz, L., Bourassa, M. G., Lespérance, J., Aldridge, H. E., Kazim, F., Salvatori, V. A., Henderson, M., Bonan, R., & David, P. R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182603 · Cited by 692
(1995) · European Journal of Neurology · doi:10.1111/j.1468-1331.1995.tb00150.x · Cited by 532
Wallis, R. M., Corbin, J. D., Francis, S. H., & Ellis, P. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00042-9 · Cited by 504
Use of Sildenafil (Viagra) in Patients With Cardiovascular Disease
Cheitlin, M. D., Hutter, A. M., Brindis, R. G., Ganz, P., Kaul, S., Russell, R. O., Zusman, R. M., Forrester, J. S., Douglas, P. S., Faxon, D. P., et al. (1999) · Circulation · doi:10.1161/01.cir.99.1.168 · Cited by 497
Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves
Stein, P. D., Alpert, J. S., Bussey, H. I., Dalen, J. E., & Turpie, A. G. G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.220s · Cited by 496
Shinohara, Y., Katayama, Y., Uchiyama, S., Yamaguchi, T., Handa, S., Matsuoka, K., Ohashi, Y., Tanahashi, N., Yamamoto, H., Genka, C., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70198-8 · Cited by 488
Adams, R. J., Albers, G., Alberts, M. J., Benavente, O., Furie, K., Goldstein, L. B., Gorelick, P., Halperin, J., Harbaugh, R., Johnston, S. C., et al. (2008) · Stroke · doi:10.1161/strokeaha.107.189063 · Cited by 481
Mills, D. C. B., & Smith, J. B. (1971) · Biochemical Journal · doi:10.1042/bj1210185 · Cited by 423
Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke
Rosendaal, F. R., & Algra, A. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)05416-6 · Cited by 393
Diener, H.-C., Sacco, R. L., Yusuf, S., Cotton, D., Ôunpuu, S., Lawton, W. A., Palesch, Y., Martin, R. H., Albers, G. W., Bath, P., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70198-4 · Cited by 359
Maurice, D. H., & Haslam, R. J. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10974-7 · Cited by 351
Gotoh, F., Tohgi, H., Hirai, S., Terashi, A., Fukuuchi, Y., Otomo, E., Shinohara, Y., Itoh, E., Matsuda, T., Sawada, T., et al. (2000) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1053/jscd.2000.7216 · Cited by 343
Thompson, P. D., Zimet, R., Forbes, W. P., & Zhang, P. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02869-2 · Cited by 312
Effect of cilostazol on platelet aggregation and experimental thrombosis
木村, 征. (1988) · Medical Entomology and Zoology · Cited by 293
The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia
Halcox, J. P. J., Nour, K. R. A., Zalos, G., Mincemoyer, R., Waclawiw, M. A., Rivera, C. E., Willie, G., Ellahham, S., & Quyyumi, A. A. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02139-3 · Cited by 274
Dipyridamole inhibition of adenosine metabolism in human blood
Klabunde, R. E. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90026-2 · Cited by 263
Pharmacology of phosphodiesterase inhibitors
(2005) · Therapeutic Strategies in COPD · doi:10.1201/b14809-12 · Cited by 261
PHARMACOLOGY OF PHOSPHODIESTERASE‐5 INHIBITORS
Corbin, J., & Francis, S. (2002) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2002.tb11296.x · Cited by 260
Regensteiner, J. G., Ware, J. E., McCarthy, W. J., Zhang, P., Forbes, W. P., Heckman, J., & Hiatt, W. R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50604.x · Cited by 251
Daenen, S., & de Vries-Hospers, H. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91741-2 · Cited by 219
The pharmacology of cilostazol
Schrör, K. (2002) · Diabetes, Obesity and Metabolism · doi:10.1046/j.1463-1326.2002.0040s2s14.x · Cited by 213
Antithrombotic Therapy in Peripheral Arterial Occlusive Disease
Clagett, G. P., Graor, R. A., & Salzman, E. W. (1992) · Chest · doi:10.1378/chest.102.4_supplement.516s · Cited by 210
Suh, J.-W., Lee, S.-P., Park, K.-W., Lee, H.-Y., Kang, H.-J., Koo, B.-K., Cho, Y.-S., Youn, T.-J., Chae, I.-H., Choi, D.-J., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.08.631 · Cited by 193
Cyclic Nucleotides and Phosphodiesterases in Platelets
Dickinson, N., Jang, E., & Haslam, R. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615861 · Cited by 162
Mechanism of action of dipyridamole
Harker, L. A., & Kadatz, R. A. (1983) · Thrombosis Research · doi:10.1016/0049-3848(83)90356-0 · Cited by 162
Faxon, D. P., Creager, M. A., Smith, S. C., Pasternak, R. C., Olin, J. W., Bettmann, M. A., Criqui, M. H., Milani, R. V., Loscalzo, J., Kaufman, J. A., et al. (2004) · Circulation · doi:10.1161/01.cir.0000128517.52533.db · Cited by 159
Translational Therapeutics of Dipyridamole
Kim, H.-H., & Liao, J. K. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.160226 · Cited by 157
Han, Y., Li, Y., Wang, S., Jing, Q., Wang, Z., Wang, D., Shu, Q., & Tang, X. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.01.006 · Cited by 153
Schwartz, B. G., & Kloner, R. A. (2010) · Circulation · doi:10.1161/circulationaha.110.944603 · Cited by 139
Dipyridamole Selectively Inhibits Inflammatory Gene Expression in Platelet–Monocyte Aggregates
Weyrich, A. S., Denis, M. M., Eyre, J. R., Spencer, E. D., Dixon, D. A., Marathe, G. K., McIntyre, T., Zimmerman, G. A., & Prescott, S. M. (2005) · Circulation · doi:10.1161/01.cir.0000154607.90506.45 · Cited by 129
Dipyridamole for preventing stroke and other vascular events in patients with vascular disease
de Schryver, E. L. L. M., Algra, A., & van Gijn, J. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001820.pub3 · Cited by 128
Aspirin Plus Dipyridamole Versus Aspirin for Prevention of Vascular Events After Stroke or TIA
Verro, P., Gorelick, P. B., & Nguyen, D. V. (2008) · Stroke · doi:10.1161/strokeaha.107.496281 · Cited by 125
Effects of selective inhibitors on cyclic nucleotide phosphodiesterases of rabbit aorta
Ahn, H. S., Crim, W. N., Romano, M., Sybertz, E. J., & Pitts, B. J. R. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90631-x · Cited by 117
Aktas, B., Utz, A. L., Hönig‐Liedl, P., Walter, U., & Geiger, J. (2003) · Stroke · doi:10.1161/01.str.0000056527.34434.59 · Cited by 116
Caffeine Alters A2AAdenosine Receptors and Their Function in Human Platelets
Varani, K., Portaluppi, F., Merighi, S., Ongini, E., Belardinelli, L., & Borea, P. A. (1999) · Circulation · doi:10.1161/01.cir.99.19.2499 · Cited by 116
Managing PAD with multiple platelet inhibitors: the effect of combination therapy on bleeding time
Wilhite, D. B., Comerota, A. J., Schmieder, F. A., Throm, R. C., Gaughan, J. P., & Rao, A. K. (2003) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(03)01029-2 · Cited by 111
Jeong, Y., Hwang, J., Kim, I., Park, Y., Hwang, S., Lee, S., Kwak, C. H., & Park, S. (2010) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.109.880179 · Cited by 99
Potentiation of anti-platelet aggregating activity of cilostazol with vascular endothelial cells
Igawa, T., Tani, T., Chijiwa, T., Shiragiku, T., Shimidzu, S., Kawamura, K., Kato, S., Unemi, F., & Kimura, Y. (1990) · Thrombosis Research · doi:10.1016/0049-3848(90)90079-r · Cited by 96
Cochrane Review: Dipyridamole for Preventing Major Vascular Events in Patients With Vascular Disease
de Schryver, E. L. L. M., Algra, A., & van Gijn, J. (2003) · Stroke · doi:10.1161/01.str.0000082381.23938.0e · Cited by 96
Kohda, N., Tani, T., Nakayama, S., Adachi, T., Marukawa, K., Ito, R., Ishida, K., Matsumoto, Y., & Kimura, Y. (1999) · Thrombosis Research · doi:10.1016/s0049-3848(99)00109-7 · Cited by 93
Aspirin Extrusion From Human Platelets Through Multidrug Resistance Protein-4–Mediated Transport
Mattiello, T., Guerriero, R., Lotti, L. V., Trifirò, E., Felli, M. P., Barbarulo, A., Pucci, B., Gazzaniga, P., Gaudio, C., Frati, L., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.03.049 · Cited by 89
Antithrombotic Therapy in Peripheral Arterial Occlusive Disease
Jackson, M. R., & Clagett, G. (2001) · CHEST Journal · doi:10.1378/chest.119.1_suppl.283s · Cited by 86
Diebold, I., Djordjevic, T., Petry, A., Hatzelmann, A., Tenor, H., Hess, J., & Görlach, A. (2009) · Circulation Research · doi:10.1161/circresaha.109.196592 · Cited by 83
ATP and the pathogenesis of COPD
Mortaz, E., Folkerts, G., Nijkamp, F. P., & Henricks, P. A. J. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.04.019 · Cited by 80
Dipyridamole, cerebrovascular disease, and the vasculature
Chakrabarti, S., & Freedman, J. E. (2008) · Vascular Pharmacology · doi:10.1016/j.vph.2007.12.004 · Cited by 79
Uchiyama, S., Demaerschalk, B. M., Goto, S., Shinohara, Y., Gotoh, F., Stone, W. M., Money, S. R., & Kwon, S. U. (2009) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2009.07.010 · Cited by 79
Potentiation and priming of platelet activation: a potential target for antiplatelet therapy
Gresele, P., Falcinelli, E., & Momi, S. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.05.002 · Cited by 78
Self-citationSorkin, E. M., & Markham, A. (1999) · Drugs & Aging · doi:10.2165/00002512-199914010-00005 · Cited by 74
Modulation of Human Platelet Aggregation by the Phosphodiesterase Type 5 Inhibitor Sildenafil
Berkels, R., Klotz, T., Sticht, G., Englemann, U., & Klaus, W. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200104000-00008 · Cited by 66
Tamai, Y., Takami, H., Nakahata, R., Ono, F., & Munakata, A. (1999) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000022512 · Cited by 64
Venkatesh, P. K., Pattillo, C. B., Branch, B., Hood, J., Thoma, S., Illum, S., Pardue, S., Teng, X., Patel, R. P., & Kevil, C. G. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq002 · Cited by 64
Dunkern, T. R., & Hatzelmann, A. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2004.07.007 · Cited by 62
Inhibition and Reversal of Platelet Aggregation by Methyl Xanthines
Ardlie, G. N., Glew, G., Schultz, B., & Schwartz, C. E. (1967) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1655076 · Cited by 62
Inhibition of Platelet Aggregation and the Release of P-Selectin from Platelets by Cilostazol
Kariyazono, H., Nakamura, K., Shinkawa, T., Yamaguchi, T., Sakata, R., & Yamada, K. (2001) · Thrombosis Research · doi:10.1016/s0049-3848(00)00415-1 · Cited by 59
Cilostazol reduces restenosis after carotid artery stenting
Takigawa, T., Matsumaru, Y., Hayakawa, M., Nemoto, S., & Matsumura, A. (2009) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2009.08.040 · Cited by 57
Dipyridamole for Preventing Stroke and Other Vascular Events in Patients With Vascular Disease
de Schryver, E. L. L. M., Algra, A., & van Gijn, J. (2008) · Stroke · doi:10.1161/strokeaha.107.499723 · Cited by 49
Cyclic GMP‐dependent vasodilatory properties of LASSBio 294 in rat aorta
Silva, C. L. M., Noël, F., & Barreiro, E. J. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704473 · Cited by 47
Effect on platelet function of cilostazol, clopidogrel, and aspirin, each alone or in combination
Comerota, A. J. (2005) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2005.09.005 · Cited by 41
Jennings, D. L., & Kalus, J. S. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009338940 · Cited by 41
A1- and A2-selective adenosine antagonists: in vivo characterization of cardiovascular effects.
Evoniuk, G. E., Jacobson, K. A., Shamim, M. T., et al. (1987) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39187-1 · Cited by 37
Weber, E., Haas, T. A., Müller, T. H., Eisert, W. G., Hirsh, J., Richardson, M., & Buchanan, M. R. (1990) · Thrombosis Research · doi:10.1016/0049-3848(90)90254-a · Cited by 35
Young, J. M. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.10.1487 · Cited by 35
Effect of antioxidants on chemiluminescence produced by reactive oxygen species
Pascual, C., & Romay, C. (1992) · Journal of Bioluminescence and Chemiluminescence · doi:10.1002/bio.1170070205 · Cited by 33
Bon, E. D., Bonanni, G., Saggiorato, G., Bassi, P., & Cella, G. (2010) · Angiology · doi:10.1177/0003319710362977 · Cited by 21
Cilostazol augments the inhibition of platelet aggregation in clopidogrel low‐responders
Lee, K., Kim, J., Yoo, B. S., Yoon, J., Hong, M. K., Ahn, M., Choe, H., & LEE, S. ‐. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04019.x · Cited by 19
Kim, C.-W., Yun, J.-W., Bae, I., et al. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.02.004 · Cited by 18
Cited by
A Brief Review of Cardiovascular Diseases, Associated Risk Factors and Current Treatment Regimes
Flora, G. D., & Nayak, M. K. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190925163827 · Cited by 476
Narouze, S., Benzon, H. T., Provenzano, D. A., Buvanendran, A., De Andres, J., Deer, T. R., Rauck, R., & Huntoon, M. A. (2015) · Regional Anesthesia and Pain Medicine · doi:10.1097/aap.0000000000000223 · Cited by 362
Pathophysiology of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: A Review
Dodd, W. S., Laurent, D., Dumont, A. S., Hasan, D. M., Jabbour, P. M., Starke, R. M., Hosaka, K., Polifka, A. J., Hoh, B. L., & Chalouhi, N. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.021845 · Cited by 315
Huang, B., Chen, Z., Geng, L., Wang, J., Liang, H., Cao, Y., Chen, H., Huang, W., Su, M., Wang, H., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.027 · Cited by 307
Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19
Liu, X., Li, Z., Liu, S., Sun, J., Chen, Z., Jiang, M., Zhang, Q., Wei, Y., Wang, X., Huang, Y.-Y., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.04.008 · Cited by 274
Metadata
- Authors
- Gresele, P., Momi, S., & Falcinelli, E.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2011-09-09
- Volume
- 72
- Issue
- 4
- Pages
- 634-646
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W1868589471
- Cited by
- 304
- References
- 73
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.